Managing adverse events of multiple myeloma and anti-multiple myeloma treatment: a perspective on carfilzomib.

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{39ad9386da244ae7b31096d365a1a4e4,

title = "Managing adverse events of multiple myeloma and anti-multiple myeloma treatment: a perspective on carfilzomib.",

author = "Siegel, \{David S.\}",

year = "2013",

month = dec,

language = "English",

volume = "27 Suppl 3",

pages = "2--3",

journal = "ONCOLOGY (United States)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

}

TY - JOUR

T1 - Managing adverse events of multiple myeloma and anti-multiple myeloma treatment

T2 - a perspective on carfilzomib.

AU - Siegel, David S.

PY - 2013/12

Y1 - 2013/12

UR - https://www.scopus.com/pages/publications/84909587323

M3 - Article

C2 - 25184229

AN - SCOPUS:84909587323

SN - 0890-9091

VL - 27 Suppl 3

SP - 2

EP - 3

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

ER -